Prenatal exams miss 66% of heart defects. Using a pre-trained vision model accelerated R&D to secure FDA clearance in 2 years.
A medical technology company founded by pediatric cardiologists focuses on detecting congenital heart defects in fetal hearts measuring less than one centimeter.
Only 34% of congenital heart defects are detected prenatally due to the complexity of ultrasound exams and the high level of expertise required. The...
“We haven’t seen anything which comes close in terms of the ratio between performance and inference speed, and so DINOv2 has been a great tool for us. We are pleased with our rapid product development traction so far, and now the goal is to get it in the hands of clinicians to accelerate improved patient care.”
AI platform for fetal heart screening during prenatal ultrasound exams.
Social technology company developing AI frameworks, VR hardware, and digital platforms.
Related implementations across industries and use cases
Manual frame-by-frame analysis slowed research. Vision AI now extracts quantitative data directly from video to predict outcomes.
Custom hardware bottlenecked imaging. A switch to software-defined GPUs now renders photorealistic 3D hearts in real time.
Mentorship meant removing doctors from care for days. Now, 32 digital hubs stream live surgeries for real-time, remote expert guidance.
Silos forced teams to manually chase data. Now, AI agents identify adverse events in seconds, eliminating weeks of cross-referencing.
Attorneys juggled fragmented tools to search 50,000 cases. An AI orchestrator now routes queries to sub-agents in a single chat.
Lab supply orders were handwritten in notebooks. Digital ordering now takes seconds, saving 30,000 hours for research annually.
Experts spent 15 minutes pulling data from scattered systems. Natural language prompts now generate detailed reports instantly.